USFDA Issues Form 483 With Eight Observations To Aurobindo's Telangana Unit
Published on: Sept. 5, 2025, 10:57 p.m. | Source: NDTV Profit
Aurobindo Pharma on Friday said the US health regulator has issued a Form 483 with eight observations after inspecting its Telangana-based manufacturing plant.
